share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:擬議出售證券
美股SEC公告 ·  08/20 05:48

牛牛AI助理已提取核心訊息

Arcutis Biotherapeutics officer, Burnett Patrick, is set to sell 1,728 shares of common stock on 08/19/2024, with an aggregate market value of $14,318. The shares were acquired on 08/18/2024 through a restricted stock vest directly from Arcutis Biotherapeutics. This transaction follows a recent history of sales by Burnett Patrick, who has sold a total of 62,978 shares in the past three months, amounting to gross proceeds of $554,489.
Arcutis Biotherapeutics officer, Burnett Patrick, is set to sell 1,728 shares of common stock on 08/19/2024, with an aggregate market value of $14,318. The shares were acquired on 08/18/2024 through a restricted stock vest directly from Arcutis Biotherapeutics. This transaction follows a recent history of sales by Burnett Patrick, who has sold a total of 62,978 shares in the past three months, amounting to gross proceeds of $554,489.
arcutis biotherapeutics官員Burnett Patrick計劃於2024年08月19日出售1,728股普通股,市值爲$14,318。這些股票於2024年08月18日通過直接從arcutis biotherapeutics獲得的受限股票授予獲得。這筆交易是Burnett Patrick最近出售的一系列交易之一,他在過去三個月內出售了總計62,978股,總收入爲$554,489。
arcutis biotherapeutics官員Burnett Patrick計劃於2024年08月19日出售1,728股普通股,市值爲$14,318。這些股票於2024年08月18日通過直接從arcutis biotherapeutics獲得的受限股票授予獲得。這筆交易是Burnett Patrick最近出售的一系列交易之一,他在過去三個月內出售了總計62,978股,總收入爲$554,489。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。